Dyne therapeutics ipo date
WebSep 12, 2024 · Dyn Therapeutics (DYN) has filed to raise $175 million from the sale of its common stock in an IPO, according to an amended registration statement.. The company is a preclinical stage developer of ... WebSep 12, 2024 · Dyn Therapeutics (DYN) has filed to raise $175 million from the sale of its common stock in an IPO, according to an amended registration statement.. The …
Dyne therapeutics ipo date
Did you know?
Web1 day ago · Get the latest dividend data for Dyne Therapeutics, Inc. (DYN), including dividend history, yield, key dates, growth and other metrics. ... IPOs. Recent IPOs; IPO Calendar; IPO Statistics; IPO News; IPO Screener; ETFs. ETF Screener; Compare Tool; ... Ex-Dividend Date n/a. Payout Frequency n/a. Payout Ratio n/a. WebMar 23, 2024 · Dyne Therapeutics sets IPO terms, to offer 10.3 million shares priced at $16 to $18 each. Sep. 10, 2024 at 7:12 a.m. ET by Ciara Linnane.
WebSep 10, 2024 · Dyne Therapeutics, a preclinical biotech developing oligonucleotide therapies for rare muscular diseases, announced terms for its IPO on Thursday. The Waltham, MA-based company plans to raise $175 ... WebDyne Therapeutics, Inc. Financial Information: Market Cap: $707.8mil: Revenues: $0 mil (last 12 months) Net Income $-28.2 mil (last 12 months) IPO Profile: Symbol: DYN: …
WebSep 1, 2024 · Dyne Therapeutics (DYN) aims to raise $100 million in an IPO of its common stock, according to an S-1 registration statement. The company is advancing a pipeline of drug treatment candidates for ... WebSep 16, 2024 · WALTHAM, Mass., Sept. 16, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing innovative life-transforming therapeutics for patients with genetically driven diseases, today announced the pricing of its initial public offering of 12,251,578
WebApr 10, 2024 · 5 brokerages have issued twelve-month target prices for Dyne Therapeutics' shares. Their DYN share price forecasts range from $18.00 to $34.00. On average, they …
WebPharmaceutical. Headquarters Regions Greater Boston Area, East Coast, New England. Founded Date 2024. Founders Phillip Samayoa, Romesh Subramanian. Operating … moberly lane apartments bentonville arWebDyne Therapeutics is registered under the ticker NASDAQ:DYN . Their stock opened with $19.00 in its Sep 16, 2024 IPO. Stock Symbol NASDAQ:DYN ; Valuation at IPO … moberly leisure centreWebSep 17, 2024 · A muscle disease company, Dyne Therapeutics ( DYN) has priced its IPO of 12,251,578 common shares at $19.00/share, for expected gross proceeds of ~$233M. … injectionvkWebSep 6, 2024 · Dyne Therapeutics Announces First Patient Dosed in Phase 1/2 DELIVER Clinical Trial of DYNE-251 for the Treatment of Duchenne Muscular Dystrophy. September 06, 2024 07:00 ET Source: Dyne ... moberly license bureauWebSep 17, 2024 · IPOs. Waltham, Massachusetts-based Dyne Therapeutics, Inc. priced its upsized initial public offering of 12.253 million shares at $19 versus the estimated price range of $16 and $18, to generate ... moberly little dixie libraryWebMar 20, 2024 · Dyne Therapeutics, Inc. (Nasdaq: DYN), a clinical-stage muscle disease company focused on advancing innovative life-transforming therapeutics for people living with genetically driven diseases ... injection vk hassanWebSep 21, 2024 · WALTHAM, Mass., Sept. 21, 2024 (GLOBE NEWSWIRE) -- Dyne Therapeutics, Inc. (Nasdaq: DYN), a muscle disease company focused on advancing … injection videos for kids youtube